Prophylactic use of granulocyte colony-stimulating factor after chemotherapy does not affect survival rate in acute myeloid leukemia: a meta-analysis

Acta Haematol. 2009;121(4):223-6. doi: 10.1159/000225909. Epub 2009 Jun 19.
No abstract available

Publication types

  • Meta-Analysis

MeSH terms

  • Acute Disease
  • Adolescent
  • Aged
  • Aged, 80 and over
  • Antineoplastic Agents / adverse effects*
  • Filgrastim
  • Granulocyte Colony-Stimulating Factor / therapeutic use*
  • Humans
  • Lenograstim
  • Leukemia, Myeloid / drug therapy
  • Leukemia, Myeloid / mortality*
  • Middle Aged
  • Neutropenia / chemically induced
  • Neutropenia / prevention & control*
  • Randomized Controlled Trials as Topic / statistics & numerical data
  • Recombinant Proteins / therapeutic use

Substances

  • Antineoplastic Agents
  • Recombinant Proteins
  • Granulocyte Colony-Stimulating Factor
  • Lenograstim
  • Filgrastim